Radioimmunoassay for 1,25-dihydroxycholecalciferol

12Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This radioimmunoassay has several unique features: a stable binding protein (the antiserum), short assay incubation, and an efficient procedure for the isolation of 1,25(OH)2D3 from serum. Analysis of the raw data by a computer program can further reduce the time and effort expended. The limited specificity of the antiserum for 1,25(OH)2D3 relative to the other metabolites of vitamin D3 is a drawback. However, the generation of antibodies with immunoreactivity against the 1α-hydroxyl function of the A ring will remove this limitation. Our preliminary experience with 1α-hydroxycholecalcioic acid as hapten has produced antisera with greater specificity for the 1α-hydroxyl position on the A ring. When such highly specific antisera are widely available, the radioiummunoassay of 1,25(OH)2D3 will be the analytical method of choice.

Cite

CITATION STYLE

APA

Gray, T. K., McAdoo, T., & Eisman, J. (1983). Radioimmunoassay for 1,25-dihydroxycholecalciferol. Clinical Chemistry, 29(1), 196–200. https://doi.org/10.1093/clinchem/29.1.196

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free